TSH Biopharm Corporation Limited

NT$58.70As of Sun 8 Nov 2026, 12:00 UTC
TPEx:8432Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR 0.49%
Div yield 4.45%
ROE 16.11%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.25
PE TTM 10.77
TSR TTM 16.92%
Mkt cap NT$2.254B
ROIC 30.95%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$62
5.54%
(77.89%)
Hold 8|2|5|10|11
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.83
0.88
0.95
0.99
3.64%
16.01%
22.10%
15.51%
RevenueNT$M
103.3
108.1
108.0
112.9
1.40%
6.05%
5.42%
13.00%
Peers (US$68.08M)
Cap (US$)
PE
59.32M
22.19x
Capital
TTM
5Y
10Y
Leveragex
1.684
(5.702)
(4.535)
EBIT/Intx
0.712
0.079
0.090
Own earn%
660.41
(12.96)
(13.97)
Sh yield%
49.66
68.98
67.32
Owners
Insiders/Inst%
14.16
69.72
Short interest%
4.20
SBC / revenue%
5.24
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
5–12
$1 testx
0.2
Incr. ROIC%
8